Keywords: Tumors (Pre-Treatment), Metabolism, 13C NMR, stable isotopomer analysis, metabolic imaging
Motivation: Metabolism plays a key role in the growth and proliferation of brain tumors including aggressive meningiomas. We previously reported that meningiomas preferentially utilize acetate as a bioenergetic substrate. However, the metabolism of acetate in the presence of glucose is not well understood.
Goal(s): To investigate the simultaneous in vivo metabolism of acetate and glucose in meningiomas.
Approach: We infused [2-13C]acetate and [U-13C]glucose as metabolic tracers in meningioma patients to determine the relative utilization of both nutrients by meningiomas.
Results: Grade-II meningiomas utilize relatively less amount of glucose (grade-II: 0.6% vs. grade-I: ~5.4%) and more acetate than grade-I meningiomas (grade-II: 45.8% vs. grade-I: ~31.24%).
Impact: No chemotherapy is available for the treatment of meningiomas. The findings from this study will be helpful in designing targeted metabolic therapy for aggressive meningiomas using small molecule inhibitors (e.g., ACSS2 inhibitor) involved in acetate metabolism.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords